NCT03607539 2023-02-27Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLCInnovent Biologics (Suzhou) Co. Ltd.Phase 3 Completed397 enrolled 15 charts
NCT00122460 2014-07-23Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)Merck KGaA, Darmstadt, GermanyPhase 3 Completed442 enrolled 18 charts